Employee Option Plans (Details) ₪ / shares in Units, $ / shares in Units, $ in Thousands |
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
Dec. 17, 2025
USD ($)
$ / shares
|
Apr. 30, 2025
$ / shares
|
Apr. 01, 2025
shares
|
May 31, 2024
$ / shares
|
May 15, 2024
₪ / shares
shares
|
Aug. 09, 2023
₪ / shares
$ / shares
shares
|
Mar. 12, 2023
₪ / shares
shares
|
May 31, 2024
shares
|
Mar. 31, 2022
USD ($)
$ / shares
shares
|
Nov. 30, 2020
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2025
ILS (₪)
shares
|
Dec. 31, 2024
USD ($)
shares
|
Dec. 31, 2023
USD ($)
shares
|
Dec. 31, 2022
shares
|
Dec. 31, 2025
ILS (₪)
₪ / shares
shares
|
Dec. 31, 2024
ILS (₪)
₪ / shares
shares
|
Jan. 31, 2023
USD ($)
$ / shares
shares
|
Aug. 31, 2021
shares
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares |
|
|
|
|
|
|
|
|
|
|
16,372
|
|
|
|
|
16,372
|
|
|
|
| Number of restricted shares |
|
|
|
|
|
|
|
|
21,000
|
|
|
|
|
|
|
|
|
15,000
|
|
| Total fair value of grant | $ |
|
|
|
|
|
|
|
|
$ 2,263
|
|
|
|
|
|
|
|
|
|
|
| Number of shares |
|
|
|
|
|
|
|
|
|
|
15,332,667
|
|
15,332,667
|
|
|
15,332,667
|
15,332,667
|
|
|
| Total compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
$ 165
|
|
$ 249
|
$ 407
|
|
|
|
|
|
| Restricted shares fully vested |
|
|
|
|
|
|
|
|
|
|
23,400
|
23,400
|
|
|
|
|
|
|
|
| Ordinary shares fully vested |
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
15,000
|
|
|
|
| Fair value of grant per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 81.8
|
|
|
|
|
|
|
|
|
| Compensation amount (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
$ 6,899
|
|
6,437
|
6,460
|
|
|
|
|
|
| Percentage of options vested |
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options exercisable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value (in New Shekels per share) | ₪ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 1
|
₪ 1
|
|
|
| Options forfeited |
|
|
|
|
|
|
|
|
|
|
346,969
|
346,969
|
|
|
|
|
|
|
|
| Exercise price per share | $ / shares |
|
$ 1,591.56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
4 years
|
|
|
|
|
|
3 years 1 month 9 days
|
3 years 1 month 9 days
|
|
|
|
|
|
|
|
| Acquisition approximate percentage |
58.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash consideration share (in Dollars per share) | $ / shares |
$ 43.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash paid (in Dollars) | $ |
$ 23,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital contribution reserve (in Dollars) | $ |
$ 15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total equity-based compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
$ 7,396
|
|
7,031
|
|
|
|
|
|
|
| Restricted ordinary shares |
|
|
504
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Recognized expenses |
|
|
|
|
|
|
|
|
|
|
$ 2,955
|
₪ 10,201
|
|
|
|
|
|
|
|
| Number of options |
|
|
|
|
|
|
|
116
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase shares |
|
|
|
|
|
|
|
116
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
|
|
|
|
|
|
1 year
|
|
|
|
|
1 year
|
|
|
|
| Annual compensation percentage |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
|
|
|
|
| Employees’ contributions percentage |
|
|
|
|
|
|
|
|
|
|
3.00%
|
3.00%
|
|
|
|
|
|
|
|
| 2021 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of restricted shares |
|
|
|
|
|
|
|
|
23,400
|
|
|
|
|
|
|
|
|
|
|
| Exercisable per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 96.7
|
|
|
|
|
|
|
|
|
|
|
| 2011 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Description of options vest |
|
|
|
|
|
|
|
|
|
66.67% of the
RSUs (i.e., 407,847 RSUs) are subject to time-based vesting that shall start as of the grant date and shall end as of December 31,
2027, subject to the continued engagement of Formula’s chief executive officer with the Company as of that date (the
“Vesting Period”); and up to 33.33% of the RSUs (i.e., 203,924 RSUs as of the date hereof) are subject to
performance-based vesting, and shall vest as of December 31, 2027 on a pro-rata basis with respect to each fiscal year (starting as
of January 1, 2020) during the Vesting Period in which the target EBITDA (as defined in the grant) is achieved, subject to the
continued engagement of Formula’s chief executive officer with the Company. At the end of the vesting period, the number of
performances-based RSUs that vests shall be equal to (i) the number of fiscal years in which the target EBITDA (as defined in the
grant) was achieved multiplied by (ii) 25,490.50 RSUs (rounded to the nearest whole number, up to a cap of 203,924 RSUs in
total).
|
|
|
|
|
|
|
|
|
|
| Compensation Expenses [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash consideration share (in Dollars per share) | $ / shares |
$ 43.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Formula [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
350,000
|
| Ordinary shares |
|
|
|
|
|
|
|
|
|
|
6,428
|
|
|
|
|
6,428
|
|
|
48,378
|
| Unrecognized compensation cost (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
$ 15,420
|
|
20,371
|
27,703
|
|
|
|
|
|
| Formula’s Compensation [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares |
|
|
|
|
|
|
|
|
|
|
1,372
|
|
|
|
|
1,372
|
|
|
|
| Ordinary shares fully vested |
|
|
|
|
|
|
|
|
|
|
2,400
|
|
|
|
|
2,400
|
|
|
|
| Matrix [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares |
|
|
|
|
20,000
|
45,000
|
920,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total fair value of grant |
|
|
|
|
|
|
|
|
|
|
|
|
7,914
|
|
|
|
₪ 27,851,000
|
|
|
| Unrecognized compensation cost (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
$ 1,787
|
|
$ 3,898
|
$ 8,808
|
|
|
|
|
|
| Percentage of options vested |
|
|
|
|
|
50.00%
|
50.00%
|
|
|
|
|
|
|
|
40.00%
|
|
|
|
|
| Options exercisable |
|
|
|
|
20,000
|
45,000
|
920,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value (in New Shekels per share) | ₪ / shares |
|
|
|
|
₪ 1
|
₪ 1
|
₪ 1
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options forfeited |
|
|
|
|
|
|
45,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share | (per share) |
|
|
|
|
₪ 78.55
|
₪ 73.73
|
₪ 71.25
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of Exercise Factor |
|
|
|
|
|
|
|
|
|
|
130.00%
|
130.00%
|
|
|
|
|
|
|
|
| Fair value options, expected volatility |
|
|
|
|
|
|
|
|
|
|
31.00%
|
31.00%
|
|
|
|
|
|
|
|
| Options expire periods |
|
|
|
|
|
|
|
|
|
|
5 years
|
5 years
|
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sapiens [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of restricted shares |
|
|
|
|
|
|
|
|
|
|
378
|
|
|
|
|
378
|
|
|
|
| Number of shares granted stock options |
|
|
|
|
|
|
|
|
|
|
266,143
|
266,143
|
145,000
|
429,500
|
|
|
|
|
|
| Intrinsic value of options exercised (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,913
|
$ 851
|
|
|
|
|
|
| Total equity-based compensation expense (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
$ 18,382
|
|
$ 2,952
|
$ 3,621
|
|
|
|
|
|
| Magic Software [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unrecognized compensation cost (in Dollars) | $ |
|
|
|
|
|
|
|
|
|
|
$ 85
|
|
|
|
|
|
|
|
|
| Exercise price per share | $ / shares |
|
|
|
$ 1,822
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,028
|
|
|
|
|
| Number of purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,028
|
|
|
|
|
| Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of restricted shares |
|
|
|
|
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
|
|
| Chief Financial Officers [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of restricted shares |
|
|
|
|
|
|
|
|
|
611,771
|
|
|
|
|
|
|
|
|
|
| 2021 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
20
|
|
|
| Total fair value of grant | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,225
|
|
| Exercisable per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 81.65
|
|
| Ordinary shares fully vested |
|
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
5
|
|
|
| Top of Range [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares vest |
|
|
|
|
|
|
|
|
21,000
|
|
|
|
|
|
|
|
|
|
|
| Total fair value of grant | ₪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
₪ 170,684,000
|
|
|
|
| Number of shares |
|
|
|
|
|
|
|
|
21,000
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares |
|
|
|
|
|
|
|
|
|
|
21,000
|
|
|
|
|
21,000
|
|
|
|
| Annual financial statements percentage |
|
|
|
|
|
|
|
|
|
|
105.00%
|
105.00%
|
|
|
|
|
|
|
|
| Top of Range [Member] | 2011 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total fair value of grant | $ |
|
|
|
|
|
|
|
|
$ 2,031
|
|
|
|
|
|
|
|
|
|
|
| Top of Range [Member] | Matrix [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value options, risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
4.53%
|
4.53%
|
|
|
|
|
|
|
|
| Bottom of Range [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares vest |
|
|
|
|
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
|
|
| Total fair value of grant | $ |
|
|
|
|
|
|
|
|
$ 232
|
|
$ 50,054
|
|
|
|
|
|
|
|
|
| Number of shares |
|
|
|
|
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares |
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
15,000
|
|
|
|
| Annual financial statements percentage |
|
|
|
|
|
|
|
|
|
|
80.00%
|
80.00%
|
|
|
|
|
|
|
|
| Bottom of Range [Member] | Matrix [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value options, risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
3.34%
|
3.34%
|
|
|
|
|
|
|
|
| Mr. Gutman [Member] | Matrix [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of restricted shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
375,000
|
|
|
|
|
| DCF [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value grant |
|
|
|
|
|
|
|
|
|
|
$ 4,474
|
|
|
|
|
₪ 15,445
|
|
|
|
| Compensation Expenses [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee Option Plans [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of restricted shares |
|
|
|
|
|
|
|
|
21,000
|
|
|
|
|
|
|
|
|
|
|